Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Injection vs Needle Tenotomy in Great Trochanteric Pain Syndrome
NCT04231357Phase 3Completed
- Start
- Dec 2019
- Primary completion
- Jan 2023
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous platelet-rich plasma in greater trochanteric pain syndrome (GTPS) (2 arms). Primary endpoints: Rate of participants that showed a clinically minimal clinically important change in function as measured by HOS at 6 months and Number of adverse events related to treatment at 3 months. Started Dec 2019; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
greater trochanteric pain syndrome (GTPS)
Beyond the preview
Go deeper on NCT04231357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231357.